Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_1
1
25%
Ph not_applicable
2
50%
Ph phase_3
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Terminated1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
66.7%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (25.0%)
Phase 31 (25.0%)
N/A2 (50.0%)

Trials by Status

completed250%
terminated125%
active_not_recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
active_not_recruitingphase_1

Apnea of Prematurity Results in Respiratory Distress and Cyanosis. Caffeine Citrate Can Treat It.

NCT06905496
completednot_applicable

Dose-Response Effect Exercise and Depression

NCT06166095
completednot_applicable

Different Radiation Dose With Concurrent Chemotherapy for Thoracic Esophageal Carcinoma

NCT02850991
terminatedphase_3

High-dose Vitamin D3 in Pancreas Cancer

NCT03472833

Clinical Trials (4)

Showing 4 of 4 trials
NCT06905496Phase 1

Apnea of Prematurity Results in Respiratory Distress and Cyanosis. Caffeine Citrate Can Treat It.

Active Not Recruiting
NCT06166095Not Applicable

Dose-Response Effect Exercise and Depression

Completed
NCT02850991Not Applicable

Different Radiation Dose With Concurrent Chemotherapy for Thoracic Esophageal Carcinoma

Completed
NCT03472833Phase 3

High-dose Vitamin D3 in Pancreas Cancer

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4